Abstract
Overactive bladder, characterized by episodes of urgency, micturition frequency, nycturia and, in majority of patients urge incontinenceaffect 20-30% of seniors 70 years and over. The treatment of choice are antimuscarininc drugs which consistently proveantimuscarinics superiority over placebo comparably so as in middle age.
In old age due to the physiologic age-associated organchanges, frequent commorbidities and polypharmacotherapy antimuscarinics with higher tissue selectivity are recommended,which do not cross blood-brain barrier and those with low risk of drug interactions. Extended release formulations with lowerrates of AE are preferred.
Scientific evidence and Incontinence Guidelines of EAU 2017 are presented with special focus on old age.